Cargando…

Association of periodontal health indicators and major depressive disorder in hospital outpatients

BACKGROUND: Major depressive disorder (MDD) has been associated with changes in behavioral, neurophysiological, and neuroendocrinological factors and thought to be one of the leading causes of disability worldwide. There are various evidences that depression and periodontitis may also be related. AI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Amit, Kardkal, Asif, Debnath, Surangama, Lakshminarayan, Jyothi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645535/ https://www.ncbi.nlm.nih.gov/pubmed/26644715 http://dx.doi.org/10.4103/0972-124X.167161

Ejemplares similares

Comparative evaluation of analgesic and anti-inflammatory efficacy of ibuprofen and traumeel after periodontal flap surgery: A randomized triple-blind clinical trial
por: Das, Revu, et al.
Publicado: (2019)

Use of methylphenidate in the treatment of major depressive disorder in an outpatient mental health center
por: Lacueva, Carolina Garnier, et al.
Publicado: (2010)

Use of antipsychotics in the treatment of major depressive disorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

Use of benzodiazpines in the treatment of major depressive disorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

Unintentional Injuries among Psychiatric Outpatients with Major Depressive Disorder
por: Hung, Ching-I, et al.
Publicado: (2016)

P300 latency as an indicator of severity in major depressive disorder
por: Tripathi, Shailendra Mohan, et al.
Publicado: (2015)

Excess cost of non-remission among outpatients with major depressive disorder
por: Woo, Jong-Min, et al.
Publicado: (2014)

Neuropeptides as the Shared Genetic Crosstalks Linking Periodontitis and Major Depression Disorder
por: Sun, Changsheng, et al.
Publicado: (2021)

Periodontal status and the efficacy of the first‐line treatment of major depressive disorder
por: Jelavić, Silvana, et al.
Publicado: (2021)

Factors associated with adherence to sports and exercise among outpatients with major depressive disorder
por: Monteiro, Fernanda Castro, et al.
Publicado: (2021)

Sensitivity and specificity of the Major Depression Inventory in outpatients
por: Cuijpers, Pim, et al.
Publicado: (2007)

Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population
por: Li, Haiyan, et al.
Publicado: (2017)

Implications of Systemic Inflammation and Periodontitis for Major Depression
por: Hashioka, Sadayuki, et al.
Publicado: (2018)

Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder
por: Jeon, Hong Jin, et al.
Publicado: (2016)

PS90. Differences in hypochondriasis between Korean and American outpatients with major depressive disorder
por: Kim, Jiyeon, et al.
Publicado: (2016)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

Clinical predictors associated with full remission versus episode of major depressive disorder outpatients: the experience at a teaching hospital in Taiwan
por: Yeh, Mei-Yu, et al.
Publicado: (2014)

Effects of herbal and non-herbal toothpastes on plaque and gingivitis: A clinical comparative study
por: Tatikonda, Aravind, et al.
Publicado: (2014)

The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up
por: Hung, Ching-I, et al.
Publicado: (2015)

Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
por: Ho, Siew Ching, et al.
Publicado: (2017)

Does Age at Onset of First Major Depressive Episode Indicate the Subtype of Major Depressive Disorder?: The Clinical Research Center for Depression Study
por: Park, Seon-Cheol, et al.
Publicado: (2014)

Usefulness of the Spanish version of the mood disorder questionnaire for screening bipolar disorder in routine clinical practice in outpatients with major depression
por: de Dios, Consuelo, et al.
Publicado: (2008)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Predictive biosignature of major depressive disorder derived from physiological measurements of outpatients using machine learning
por: Ricka, Nicolas, et al.
Publicado: (2023)

Attribution retraining group therapy for outpatients with major depression disorder, generalized anxiety disorder, and obsessive-compulsive disorder: a pilot study()
por: Wang, Chun, et al.
Publicado: (2011)

HSD99 Telemedicine and the Utilization of Outpatient Mental Health Services By Patients with Incident Major Depressive Disorder during the COVID-19 Pandemic
por: Axeen, S., et al.
Publicado: (2023)

Use of mood stabilizer drugs in the treatment of major depressive dissorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

Depression and anxiety disorders among gastroenterologic outpatients
por: Tasci, Ilker, et al.
Publicado: (2014)

The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review
por: van Hees, Madelon L J M, et al.
Publicado: (2013)

Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data
por: Shin, Cheolmin, et al.
Publicado: (2019)

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021)

Comparison of effect of curcumin gel and noneugenol periodontal dressing in tissue response, early wound healing, and pain assessment following periodontal flap surgery in chronic periodontitis patients
por: Meghana, M. Venkata Sai, et al.
Publicado: (2020)

Multiple Complement Pathway-related Proteins Might Regulate Immunopathogenesis of Major Depressive Disorder
por: Reddy, Preethi V., et al.
Publicado: (2023)

Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)

Global Functional Connectivity Analysis Indicating Dysconnectivity of the Hate Circuit in Major Depressive Disorder
por: Pan, Pan, et al.
Publicado: (2022)

The Pyroptosis-Related Signature Predicts Diagnosis and Indicates Immune Characteristic in Major Depressive Disorder
por: Deng, Zhifang, et al.
Publicado: (2022)

Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder
por: Dong, Zaiquan, et al.
Publicado: (2022)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Ayurveda management of Major Depressive Disorder: A case study
por: Tubaki, Basavaraj R., et al.
Publicado: (2021)

Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study
por: Woo, Jong-Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5s0rpi0uk64um1scihhfnen42m